Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7167-7179

  Irwin, Chad R ^a   Evans, David H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN F11; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

A33R GENE; A34R GENE; ACTIN FILAMENT; ANIMAL CELL; ARTICLE; B5R GENE; CELL MOTION; CONTROLLED STUDY; F11 GENE; GENE EXPRESSION REGULATION; INHIBITION KINETICS; MYXOMA VIRUS; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; MYXOMA VIRUS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; STRESS FIBERS; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRAL PROTEINS;

MYXOMA VIRUS; ORTHOPOXVIRUS; VACCINIA VIRUS;

EID: 84864126587     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06936-11     Document Type: Article

References (65)

1. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M. 2007. The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1:227-240.
2. Arakawa Y, Cordeiro JV, Way M. 2007. F11L-mediated inhibition of RhoA-mDia signaling stimulates microtubule dynamics during vaccinia virus infection. Cell Host Microbe 1:213-226.
3. Barry M, et al. 1997. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology 239:360-377.
4. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S. 2004. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17:349-356.
5. Bennett CJ, Webb M, Willer DO, Evans DH. 2003. Genetic and phylogenetic characterization of the type II cyclobutane pyrimidine dimer photolyases encoded by leporipoxviruses. Virology 315:10-19.
6. Blasco R, Cole NB, Moss B. 1991. Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein. J. Virol. 65:4598-4608.
7. Borrego B, Lorenzo MM, Blasco R. 1999. Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively. J. Gen. Virol. 80:425-432.
8. Chan KY, Haschke RH. 1982. Isolation and culture of corneal cells and their interactions with dissociated trigeminal neurons. Exp. Eye Res. 35: 137-156.
9. Chan WM, Kalkanoglu AE, Ward BM. 2010. The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus. Virology 408:109-118.
10. Chan WM, Ward BM. 2010. There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions. Virology 402:83-93.
11. Chang SJ, Chang YX, Izmailyan R, Tang YL, Chang W. 2010. Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. J. Virol. 84:8422-8432.
12. Cordeiro JV, et al. 2009. F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection. PLoS One 4:e8506. doi:10.1371/ journal.pone.0008506.
13. Doceul V, Hollinshead M, van der Linden L, Smith GL. 2010. Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327:873-876.
14. Dodding MP, Newsome TP, Collinson LM, Edwards C, Way M. 2009. An E2-F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection. Cell Microbiol. 11:808-824.
15. Dodding MP, Way M. 2009. Nck-and N-WASP-dependent actin-based motility is conserved in divergent vertebrate poxviruses. Cell Host Microbe 6:536-550.
16. Domi A, Weisberg AS, Moss B. 2008. Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread. J. Virol. 82:4215-4226.
17. Duteyrat JL, Gelfi J, Bertagnoli S. 2006. Ultrastructural study of myxoma virus morphogenesis. Arch. Virol. 151:2161-2180.
18. Earley AK, Chan WM, Ward BM. 2008. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J. Virol. 82:2161-2169.
19. Engelstad M, Howard ST, Smith GL. 1992. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801-810.
20. Engelstad M, Smith GL. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627-637.
21. Gammon DB, et al. 2010. Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathog. 6:e1000984. doi:10.1371/journal.ppat.1000984.
22. Gasteiger E, et al. 2005. Protein identification and analysis tools on the ExPASy server, p 571-607. In Walker JM (ed), The proteomics protocols handbook. Humana Press, Totowa, NJ.
23. Griffith M, Trinkause-Randall V, Watsky MA, Liu C-Y, Sheardown H. 2002. Cornea, p 131-140. In Atala A, Lanza R (ed), Methods of tissue engineering. Academic Press, San Diego, CA.
24. Herrero-Martinez E, Roberts KL, Hollinshead M, Smith GL. 2005. Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J. Gen. Virol. 86: 2961-2968.
25. Husain M, Weisberg AS, Moss B. 2007. Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells. Virology 366:424-432.
26. Isaacs SN, Wolffe EJ, Payne LG, Moss B. 1992. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66:7217-7224.
27. Izmailyan RA, Huang CY, Mohammad S, Isaacs SN, Chang W. 2006. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80:8402-8410.
28. Kato SE, Greco FA, Damaso CR, Condit RC, Moussatche N. 2004. An alternative genetic method to test essential vaccinia virus early genes. J. Virol. Methods 115:31-40.
29. Katsafanas GC, Moss B. 2007. Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host Microbe 2:221-228.
30. Katz E, Ward BM, Weisberg AS, Moss B. 2003. Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. J. Virol. 77: 12266-12275.
31. Kirn DH, Wang Y, Liang W, Contag CH, Thorne SH. 2008. Enhancing poxvirus oncolytic effects through increased spread and immune evasion. Cancer Res. 68:2071-2075.
32. Law M, Smith GL. 2004. Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. Methods Mol. Biol. 269:187-204.
33. Lin YC, et al. 2008. Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly. J. Virol. 82:5922-5932.
34. Lun X, et al. 2005. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas. Cancer Res. 65:9982-9990.
35. McIntosh AA, Smith GL. 1996. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70:272-281.
36. Mercer J, et al. 2010. Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc. Natl. Acad. Sci. U. S. A. 107:9346-9351.
37. Morales I, et al. 2008. The vaccinia virus F11L gene product facilitates cell detachment and promotes migration. Traffic 9:1283-1298.
38. Morgan GW, et al. 2010. Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog. 6:e1000785. doi:10.1371/journal.ppat.1000785.
39. Moss B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
40. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR. 1990. Product review. New mammalian expression vectors. Nature 348:91-92.
41. Newsome TP, Scaplehorn N, Way M. 2004. SRC mediates a switch from microtubule-to actin-based motility of vaccinia virus. Science 306:124-129.
42. Opgenorth A, Graham K, Nation N, Strayer D, McFadden G. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:4720-4731.
43. Purcell DA, Clarke JK. 1972. Some aspects of the morphogenesis of myxoma virus in vivo. Arch. Gesamte Virusforsch. 39:369-375.
44. Roberts KL, Smith GL. 2008. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 16:472-479.
45. Roper RL, Payne LG, Moss B. 1996. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:3753-3762.
46. Roper RL, Wolffe EJ, Weisberg A, Moss B. 1998. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72: 4192-4204.
47. Rottger S, Frischknecht F, Reckmann I, Smith GL, Way M. 1999. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:2863-2875.
48. Sanderson CM, Frischknecht F, Way M, Hollinshead M, Smith GL. 1998. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J. Gen. Virol. 79:1415-1425.
49. Sanderson CM, Hollinshead M, Smith GL. 2000. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J. Gen. Virol. 81:47-58.
50. Satheshkumar PS, Moss B. 2009. Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses. J. Virol. 83:12822-12832.
51. Smith GL, Vanderplasschen A, Law M. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
52. Sypula J, Wang F, Ma Y, Bell J, McFadden G. 2004. Myxoma virus tropism in human tumor cells. Gene Ther. Mol. Biol. 8:103-114.
53. Teoh ML, Turner PV, Evans DH. 2005. Tumorigenic poxviruses upregulate intracellular superoxide to inhibit apoptosis and promote cell proliferation. J. Virol. 79:5799-5811.
54. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H. 1993. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:163-178.
55. Valderrama F, Cordeiro JV, Schleich S, Frischknecht F, Way M. 2006. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling. Science 311:377-381.
56. van Eijl H, Hollinshead M, Rodger G, Zhang WH, Smith GL. 2002. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 83:195-207.
57. Villa NY, et al. 2010. Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells. Virology 401:266-279.
58. Ward BM. 2011. The taking of the cytoskeleton one two three: how viruses utilize the cytoskeleton during egress. Virology 411:244-250.
59. Ward BM, Weisberg AS, Moss B. 2003. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 77:4113-4126.
60. Wolfe CL, Moss B. 2011. Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex. Virology 412:278-283.
61. Wolffe EJ, Katz E, Weisberg A, Moss B. 1997. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J. Virol. 71:3904-3915.
62. Wolffe EJ, Weisberg AS, Moss B. 1998. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 244:20-26.
63. Wolffe EJ, Weisberg AS, Moss B. 2001. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 75:303-310.
64. Zhang WH, Wilcock D, Smith GL. 2000. Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J. Virol. 74:11654-11662.
65. Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G. 2010. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virusinduced cell motility but not growth in human and murine cells. Virology 404:231-239.